The American College of Physicians criticized that the 2017 blood pressure (BP) guideline may fall short in weighing the potential benefits against potential harms, costs, and anticipated variation in individual patient preferences, especially for average- and lower-risk adults 60 and older. Other experts echoed some of the same concerns, arguing against a one-size-fits-all BP goal. It may be reasonable to consider more aggressive treatment goals in the highest-risk patients. For everyone else, it may be more reasonable to continue defining hypertension as a BP of 140/90 mm Hg or higher and to take an individualized approach, especially for those with poor vascular compliance (i.e., pulse pressures above 80 to 90 mm Hg), who typically have dizziness and poor mentation as their systolic BP approaches 140 mm Hg; for many people over 70 with isolated systolic hypertension. Source: http://annals.org/; http://www.nejm.org/

hyangiu

Recent Posts

Function-Guided Complete Revascularization Improves Outcomes in STEMI

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete coronary…

3 hours ago

2026 Fifth Universal Definition of Myocardial Infarction

The Fifth Universal Definition of Myocardial Infarction (MI) updates the classification of MI by defining…

4 hours ago

Updated US Guideline on Pharmacologic Prevention of Migraine in Adults

The US updated evidence-based recommendations provide clinicians with comprehensive guidance on when to initiate pharmacologic…

8 hours ago

Catheter-Directed Thrombolysis Improves Outcomes in Intermediate-High–Risk Pulmonary Embolism

In patients with intermediate-high–risk acute pulmonary embolism, catheter-directed thrombolysis with alteplase plus anticoagulation significantly reduced…

1 day ago

Atorvastatin Prevents Cardiovascular Events in Older Adults without Prior Cardiovascular Disease

In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by…

3 days ago

Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HCM

In patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), aficamten significantly improved exercise capacity and patient-reported…

4 days ago

This website uses cookies.